PRESS RELEASE published on 07/06/2026 at 07:00, 2 months 20 days ago Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026 Carvolix presents promising clinical data on the TAVIPILOT platform at New York Valves 2026, showing excellent results for aortic valve positioning. The AI-driven software and robot aim to revolutionize TAVI procedures AI-driven Clinical Data Carvolix TAVIPILOT New York Valves 2026
BRIEF published on 06/24/2026 at 07:35, 3 months 2 days ago Carvolix Secures €10 Million in Funding for its Development Program Funding Medicine Carvolix TAVIPILOT Venture Debt
BRIEF published on 06/24/2026 at 07:35, 3 months 2 days ago Carvolix Gains EUR 10m Tranche, Reaching EUR 20m in Financing Medical Technology Shareholder Confidence AI-driven Robotics Venture Debt Carvolix Financing
PRESS RELEASE published on 06/24/2026 at 07:30, 3 months 2 days ago Carvolix Secures New EUR 10m Tranche, Bringing Total Financing to EUR 20m as Part of its EUR 30m Programme Carvolix secures new EUR 10m tranche, bringing total financing to EUR 20m as part of its EUR 30m programme. Proceeds for commercialization and regulatory advancements Financing Regulatory Developments Carvolix TAVIPILOT EUR 10m
BRIEF published on 06/15/2026 at 17:50, 3 months 11 days ago Carvolix: Positive results at 3 years for the Kalios™ mitral ring Mitral Regurgitation Clinical Results Carvolix Kalios Mitral Ring
BRIEF published on 06/15/2026 at 17:50, 3 months 11 days ago Carvolix Reports Positive 3-Year Results for Kalios™ Mitral Ring Mitral Regurgitation Clinical Results Kalios™ Carvolix Adjustable Mitral Ring
PRESS RELEASE published on 06/15/2026 at 17:45, 3 months 11 days ago Carvolix announces positive 3-years clinical results for Kalios™ , the only adjustable mitral ring. 100% of patients met primary endpoint for mitral regurgitation. Carvolix announces positive 3-year clinical results for Kalios™, the adjustable mitral ring, with 100% of patients meeting primary endpoint for mitral regurgitation. Company plans FDA submission in 2027 FDA Submission Clinical Results Carvolix Kalios Mitral Ring
BRIEF published on 06/15/2026 at 17:45, 3 months 11 days ago Carvolix Announces the Number of Voting Rights as of May 31, 2026 Share Capital Voting Rights Financial Transparency Medical Afflict Carvolix
BRIEF published on 05/20/2026 at 17:45, 4 months 6 days ago Carvolix: Details on Share Capital and Voting Rights as of April 30, 2026 Share Capital Voting Rights Euronext Number Of Shares Carvolix
BRIEF published on 05/04/2026 at 08:05, 4 months 22 days ago Carvolix Reports Positive Outcomes of TAVIPILOT AI Software in Clinical Studies AI Software Carvolix TAVIPILOT Post-marketing Clinical Study Transcatheter Aortic Valve Implantation
Published on 09/26/2026 at 01:00, 1 day ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 1 day 3 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 1 day 8 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 1 day 10 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/26/2026 at 15:30, 10 hours 17 minutes ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 10 hours 31 minutes ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 18 hours 2 minutes ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/26/2026 at 00:01, 1 day 1 hour ago Photon Energy N.V. Sells 7.6 MWp of PV Operational Assets in Slovakia
Published on 09/25/2026 at 18:30, 1 day 7 hours ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 17:40, 1 day 8 hours ago Availability of the 2026 half-year financial report
Published on 09/24/2026 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: Availability of the interim financial report to June 30, 2026
Published on 09/24/2026 at 18:00, 2 days 7 hours ago GUILLEMOT CORPORATION: 2026 CONSOLIDATED INTERIM RESULTS
Published on 09/24/2026 at 17:45, 2 days 8 hours ago Cegedim first-half 2026 results: profitability continues to improve